Neurotech Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Lincoln RI United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2007
NCT00447980
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Neurotech Pharmaceuticals | Neurotech Pharmaceuticals, Inc.